GnRH agonist combined with add-back therapy in the treatment of endometriosis

In: The Chinese Journal of Human Sexuality · 2012 · W2366833707
article OA: closed CC0
View on OpenAlex

Abstract

Objectives: To explore the effect of gonadotropin releasing hormone agonist(GnRH agonist) combined with add-back therapy for the treatment of endometriosis.Methods: A total of 102 patients with endometriosis were randomly divided into three groups: 50 patients treated with gonadotropin releasing hormone agonist(GnRH-a) combined with add-back therapy(group Ⅰ),28 patients treated with GnRH-a withdrawal therapy(group Ⅱ),24 patients included as the control group(group Ⅲ).The three groups were compared in terms of curative efficacy,pituitary ovarian axis endocrine changes and side effects.Results: The total effective rates in Group I and II were respectively 96% and 85.7%,significantly higher than the rate of 75% in Group Ⅲ(P0.05)75%.Patients in group Ⅰ and Ⅱ showed significantly decreased level of serum E2,FSH,LH,P(P0.05),but little changes in bone mineral density(P0.05).Conclusion: The use of GnRH-a combined with add-back therapy have better effect than withdrawal therapy and conventional treatment for endometriosis.It can restore the normal endocrine function and produce little side effects.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK